Skip to main content
BrainCited

PQQ (Pyrroloquinoline Quinone) لـ Age-Related Cognitive Decline

C

A double-blind RCT of 64 subjects found 21.5 mg/day PQQ improved memory, attention, and cognitive function after 12 weeks. A separate trial in MCI patients showed cerebral oxygenation increased from 48.4% to 52.8%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dpqq\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

الخلاصة

A double-blind RCT of 64 subjects found 21.5 mg/day PQQ improved memory, attention, and cognitive function after 12 weeks. A separate trial in MCI patients showed cerebral oxygenation increased from 48.4% to 52.8%.

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind
The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in …
Dose: None مقابل: Placebo Outcome: Cognitive function التأثير: None P = 0.01

المجتمع المدروس: Alzheimer's disease patients

Key Statistics

4

الدراسات

200

المشاركون

Positive

C

التقييم

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
10-20 mg/day
cognitivesupport:
20 mg/day

الحد الأعلى: Not established; well-tolerated up to 60 mg/day

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None 6 weeks Neutral --

أفضل وقت للتناول: With meals

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Headache
  • Insomnia
  • Mild fatigue

التفاعلات المعروفة

  • No significant drug interactions established

الحد الأقصى المسموح به: Not established; well-tolerated up to 60 mg/day

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does PQQ (Pyrroloquinoline Quinone) help with Age-Related Cognitive Decline?
Based on 4 studies with 200 participants, there is limited but promising evidence that PQQ (Pyrroloquinoline Quinone) may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much PQQ (Pyrroloquinoline Quinone) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 10-20 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of PQQ (Pyrroloquinoline Quinone)?
Reported side effects may include Headache, Insomnia, Mild fatigue. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for PQQ (Pyrroloquinoline Quinone) and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.